Determinants of Drug Metabolism in Early Neonatal Life (original) (raw)

Developmental Pharmacokinetics: Drug Disposition Relative to Age

Michelle Bestic

2014

View PDFchevron_right

Developmental pharmacokinetics of opioids in neonates

Sinno Simons

Journal of Opioid Management

View PDFchevron_right

Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug Literature

Dale Hattis, Rob Goble

Toxicological Sciences, 2002

View PDFchevron_right

Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units

Siavosh Naji-Talakar

Expert Opinion on Drug Metabolism & Toxicology, 2021

View PDFchevron_right

Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent-Metabolite Population Pharmacokinetic Model

Catherine M T Sherwin

Clinical pharmacokinetics, 2016

View PDFchevron_right

Newborns, Older Children, and Adults Comparisons of Pharmacokinetics and Pharmacokinetic Variability

Robert Goble

View PDFchevron_right

Pharmacokinetics of drugs: newborn perspective

Sarfaraz Momin

Pediatric Medicine

View PDFchevron_right

Pediatric Pharmacokinetic Data: Implications for Environmental Risk Assessment for Children

Richard K Miller

Pediatrics, 2004

View PDFchevron_right

Pharmacokinetics in the newborn

Jane Alcorn

Advanced Drug Delivery Reviews, 2003

View PDFchevron_right

Pharmacogenomics in the newborn

Iliana Bersani

Journal of Pediatric and Neonatal Individualized Medicine, 2013

View PDFchevron_right

Improving Predictive Modeling in Pediatric Drug Development: Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling

Donald Mattison

Annals of the New York Academy of Sciences, 2005

View PDFchevron_right

Acetaminophen Developmental Pharmacokinetics in Premature Neonates and Infants

Tom Hansen

Anesthesiology, 2002

View PDFchevron_right

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Pilar Tejada

Pharmaceutics, 2011

View PDFchevron_right

Physiologically-based pharmacokinetic models for children: Starting to reach maturation?

Frans Russel

Pharmacology & Therapeutics, 2020

View PDFchevron_right

Using ontogeny information to build predictive models for drug elimination

Jane Alcorn

Drug Discovery Today, 2008

View PDFchevron_right

A pharmacokinetic standard for babies and adults

Nick Holford

Journal of Pharmaceutical Sciences, 2013

View PDFchevron_right

Evident bias in a paracetamol metabolite population pharmacokinetic model applied to an external dataset

Catherine M T Sherwin

British Journal of Clinical Pharmacology, 2018

View PDFchevron_right

Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 Maturation

An Vermeulen

Aaps Journal, 2015

View PDFchevron_right

A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children

G A Woollard

British Journal of Clinical Pharmacology, 2000

View PDFchevron_right

Neonatal pharmacology—a practical approach

David mackintosh

Indian Journal of Pediatrics, 1986

View PDFchevron_right

Overview of Clinical Pharmacokinetics in Pediatrics: Possible Implications in Therapy

Herbert Obu

Biomedical & Pharmacology Journal, 2014

View PDFchevron_right

Drug metabolism in the paediatric population and in the elderly

Michael Canning

Drug Discovery Today, 2007

View PDFchevron_right

Pharmacokinetics and metabolomics in paediatric studies

Maria Engracia Encarnacion R

2016

View PDFchevron_right

Maturation of cytochrome P450 3A mediated drug metabolism: Towards individualized dosing in children

ibrahim ince

2013

View PDFchevron_right

Impact of Hepatic CYP3A4 Ontogeny Functions on Drug–Drug Interaction Risk in Pediatric Physiologically‐Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case Study

Marylore Chenel

Clinical Pharmacology & Therapeutics, 2020

View PDFchevron_right

Developmental paediatric anaesthetic pharmacology

Tom Hansen

Anaesthesia & Intensive Care Medicine, 2012

View PDFchevron_right

State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development

Catherine M T Sherwin

Clinical pharmacokinetics, 2018

View PDFchevron_right

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

Mélanie Wilbaux

Clinical Pharmacokinetics, 2015

View PDFchevron_right

A Developmental Approach to Drug-induced Liver Injury in Newborns and Children

Gavino Faa

Current Medicinal Chemistry, 2012

View PDFchevron_right

Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling

francois bouzom

Fundamental & Clinical Pharmacology, 2008

View PDFchevron_right

PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants

Alexander Vinks

CPT: pharmacometrics & systems pharmacology, 2018

View PDFchevron_right

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments

Elke Krekels

CPT: pharmacometrics & systems pharmacology, 2018

View PDFchevron_right

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs

Ramy Abdelrahman

Pharmaceutics, 2020

View PDFchevron_right

European regulatory perspective on pediatric physiologically based pharmacokinetic models

Anna Nordmark

International Journal of Pharmacokinetics, 2017

View PDFchevron_right

Paracetamol and metabolite pharmacokinetics in infants

Nick Holford

European Journal of Clinical Pharmacology, 2003

View PDFchevron_right